1 / 3

Albumin (as Excipient) Industry Research Report - Forecast to 2023

Albumin (as Excipient) Industry Research Report - Forecast to 2023 <br>

Rohitravan
Download Presentation

Albumin (as Excipient) Industry Research Report - Forecast to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Albumin (as Excipient) Industry Albumin (as Excipient) Industry 2019 and Regional and Regional Analysis Analysis Expected 2019 – – Trend Analysis by Top Key Players, Segmentation, Size Trend Analysis by Top Key Players, Segmentation, Size Expected to Boost to Boost Global Industry Growth Global Industry Growth of of 6.1% 6.1% by 2023 by 2023 Market Introduction The global Albumin (as Excipient) Industry is expected to grow at an approximate CAGR of 6.1% during forecast period, 2018–2023. The choice of excipient is an important factor in the formulation of pharmaceuticals. Albumin as excipient in formulation has been reported to improve lyophilized cake formation, dissolving properties of API from lyophilized powder, and solubility. Rising adoption of recombinant albumin-based drug delivery systems by pharmaceutical and biotechnology companies is one of the key factors driving the Albumin (as Excipient) Industry. Inquire for Free Sample at https://www.marketresearchfuture.com/sample_request/7442 Various other factors such as increasing prevalence of chronic conditions, technological advancements, emerging markets in APAC and RoW, rising awareness about albumin as excipient, and increase in usage of albumin for non-therapeutic applications are also expected to propel the growth of the market. Key Players Some of the key players in the global Albumin (as Excipient) Industry are • • • • • • • • • • • • • • • • • • • Albumedix A/S Albumin Therapeutics LLC Baxalta Incorporated Baxter International Inc. Biotest AG CSL Behring LLC Celgene China Biologic Products Inc. Grifols International S.A HiMedia Laboratories Pvt. Ltd. InVitria Medxbio Pte Ltd. Mitsubishi Tanabe Pharma Corporation Octapharma AG RayBiotech Inc. SeraCare Life Sciences Sigma-Aldrich Co. (Merck KGaA) and others. Albumin (as Excipient) Industry Segmentation The global Albumin (as Excipient) Industry is segmented based on type, application, end user, and region. The global market for albumin (as excipient), by type is segmented into human serum albumin, bovine serum albumin, and recombinant albumin. The human serum albumin segment is anticipated to hold Market Research Future | Magarpatta Road, Hadapsar, Pune.

  2. the largest market share owing to the increasing cases of chronic conditions such as, cardiac disorders, infectious diseases, and others. Based on application, the market is segmented into drug formulation, drug delivery, vaccines, medical device coating, culture media & stabilizers, diagnostics, in vitro fertilization, and others. Based on end user, the market is segmented into pharmaceutical & biotechnology industry, academic and research institutes, and others. Browse Complete Premium Research Report Enabled with Detailed TOC at https://www.marketresearchfuture.com/reports/albumin-market-7442 Intended Audience Government and Private Laboratories Research and Development (R&D) companies Biotechnology Laboratories Market Research and Consulting Service Providers • • • • Albumin (as Excipient) Industry Regional Analysis The Americas dominated the global market for albumin (as excipient) owing to the rising R&D investments and increasing prevalence of diabetes within the region. According to the 2015 data suggested by the Centres for Disease Control and Prevention (CDC), around 30.3 million Americans were suffering from diabetes. In 2017, it was estimated that Europe stood second in the global Albumin (as Excipient) Industry. This can be attributed to the increasing technological advancements, and rising participation of market players. For instance, in 2016, a Denmark based company, Novozymes launched its recombinant albumin business as a new independent called Albumedix. Asia Pacific was projected to be the fastest growing region in 2017. Increasing healthcare expenditure drives the regional markets of the Asia Pacific region. As per the data suggested by the Australian Institute of Health and Welfare, from 2015 to 2016, the total health expenditure was USD 181 billion. On the other hand, the Middle East and Africa held least share in the global Albumin (as Excipient) Industry due to inadequate economic development, especially within the African region. Inquire for exclusive Discount at https://www.marketresearchfuture.com/check-discount/7442 TABLE OF CONTENTS: Chapter 1. Report Prologue Chapter 2. Market Introduction Chapter 3. Research Methodology Chapter 4. Market Dynamics 4.1 Drivers 4.2 Restraints 4.3 Opportunities 4.4 Macroeconomic Indicators Market Research Future | Magarpatta Road, Hadapsar, Pune.

  3. 4.5 Trends & Assessment Chapter 5. Market Factor Analysis 5.1 Porter’s Five Forces Analysis 5.1.1 Bargaining Power Of Suppliers 5.1.2 Bargaining Power Of Buyers 5.1.3 Threat Of New Entrants …to be continued. About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future | Magarpatta Road, Hadapsar, Pune.

More Related